Why the FDA is cracking down on compound GLP 1 drugs for weight loss Scientific American The recommended discontinuation of GLP 1 receptor agonists during pregnancy was associated with more gestational weight gain and higher risks of pregnancy complications, according to a new analysis. Read more at: https: www.medpagetoday.com obgyn What to Expect When Taking Semaglutide Vita Pure IV GLP 1: The Diabetes Drug Changing How We Think About Weight Loss GLP 1 Microdosing: Hype or Helpful? You've probably heard the buzz around GLP 1 medications but what is microdosing, and who might it actually benefit? In our latest blog, we break